TRIA-662

· Cortria Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TRIA-662, covering 2013-08-22 to 2016-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study to Evaluate the Lipid Effects of TRIA-662 [Phase 2]